On February 5, 2026, the FDA announced a new approach regarding “no artificial colors” labeling claims. This change allows some products to be labeled as such, even if they contain colors derived from petroleum, traditionally marked as synthetic. This is a significant shift from the FDA’s previous stance where many petroleum-based additives were categorized as artificial.
The FDA’s updated policy aims to make labeling clearer for consumers. In recent years, there’s been growing public concern about artificial dyes in food, which has pushed the FDA to rethink its regulations. This shift raises important questions for manufacturers about how to market their products.
The key takeaway is that the FDA will not object to certain “no artificial colors” claims if the additives typically regarded as artificial are absent. This means that companies might consider revising their labels to align with the new enforcement guidelines. However, they need to tread carefully. Just because the FDA is taking a softer stance doesn’t mean they are entirely off the hook legally. There is still the risk of lawsuits related to misleading advertising or deceptive labeling.
Food businesses may have the chance to rethink their labeling strategies, especially for products that previously didn’t qualify for “no artificial colors” claims. Yet, they should also remember that this policy doesn’t change the basic rules against false labeling under the Federal Food, Drug, and Cosmetic Act. David Graham, a Senior Counsel, noted, “It is important to monitor FDA’s changing views of regulation and enforcement… which makes planning particularly challenging.”
While the FDA’s announcement is significant, it also comes amid political discussions about synthetic food dyes and ultra-processed foods. Advocacy groups are calling for stronger regulations against these dyes, while some industry representatives argue that the current additives are safe.
From a practical perspective, manufacturers should carefully analyze their ingredients and ensure any labeling claims are backed by solid evidence. They need to consider how consumers will perceive their claims and what legal risks they might face. In states with active consumer litigation—like California—businesses should keep these challenges in mind.
In conclusion, the FDA’s new policy opens the door for some companies to market their products differently. However, this flexibility comes with challenges and risks that need careful management. For more information on FDA regulations, you can check their official guidance here.
